Clopidogrel/aspirin - Chong Kun Dang
Alternative Names: Aspirin/clopidogrel - Chong Kun Dang; CoprigrelLatest Information Update: 24 Oct 2021
At a glance
- Originator Chong Kun Dang
- Class 2 ring heterocyclic compounds; Antiplatelets; Antipyretics; Chlorobenzenes; Esters; Pyridines; Salicylic acids; Small molecules; Thienopyridines
- Mechanism of Action Cyclooxygenase inhibitors; Platelet aggregation inhibitors; Purinergic P2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Coronary artery disease
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Coronary artery disease(In volunteers) in South Korea (PO)
- 09 Mar 2013 Pharmacokinetics and adverse events data from a Phase-I trial in Coronary artery disease (in volunteers) presented at the 114th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT-2013)
- 01 Sep 2011 Phase-I development is ongoing in South Korea